Showing results (2061-2070 of 2,091) with videos related to

Sort By:
Pageof 210
Scientific Reports|October 12, 2021
Association between phosphate and long-term outcome in CAD patients underwent coronary interventionTsung-Ying Tsai, Pai-Feng Hsu, Cheng-Hsueh Wu, et al.
Nature|August 27, 2010
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSAndrew C Elden, Hyung-Jun Kim, Michael P Hart, et al.
BMC Cancer|October 25, 2019
Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled studyJun Li, Xiang-Xing Kong, Jiao-Jiao Zhou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary interventionTsung-Ying Tsai, Hsin-Bang Leu, Pai-Feng Hsu, et al.
Journal of the Chinese Medical Association : JCMA|October 10, 2023
Sex and age differences of major cardiovascular events in patients after percutaneous coronary interventionYa-Ling Yang, Su-Chan Chen, Cheng-Hsueh Wu, et al.
Immunity|February 22, 2023
The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infectionAnna-Friederike Marx, Sandra M Kallert, Tobias M Brunner, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Monica S Montesinos, Yann Grobs, et al.
Nature|February 9, 2018
Evolutionary history of the angiosperm flora of ChinaLi-Min Lu, Ling-Feng Mao, Tuo Yang, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK InhibitorsHa-Soon Choi, Paul V Rucker, Zhicheng Wang, et al.
Circulation|January 20, 2025
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah-Eve Lemay, Mónica S Montesinos, Yann Grobs, et al.
Pageof 210